U.S. flag

An official website of the United States government

NM_000518.4(HBB):c.316-106C>G AND beta Thalassemia

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Jul 5, 2016
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000029978.3

Allele description

NM_000518.4(HBB):c.316-106C>G

Gene:
HBB:hemoglobin subunit beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_000518.4(HBB):c.316-106C>G
Other names:
IVS2-745C>G
HGVS:
  • NC_000011.10:g.5225832G>C
  • NG_000007.3:g.71784C>G
  • NM_000518.4:c.316-106C>G
  • NC_000011.9:g.5247062G>C
Nucleotide change:
IVS2, C-G, +745
Links:
OMIM: 141900.0367; dbSNP: rs34690599
NCBI 1000 Genomes Browser:
rs34690599
Molecular consequence:
  • NM_000518.4:c.316-106C>G - intron variant - [Sequence Ontology: SO:0001627]
Observations:
2

Condition(s)

Name:
beta Thalassemia (BTHAL)
Identifiers:
MedGen: C0005283; Orphanet: 848; OMIM: 613985

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000040709GeneReviews
no assertion criteria provided
Pathogenic
(May 14, 2015)
germlineliterature only

Citation Link,

SCV000052633Laboratory Corporation of America
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
pathogenic
(Aug 18, 2011)
germlinecuration, clinical testing

PubMed (25)
[See all records that cite these PMIDs]

Citation Link,

SCV000331532EGL Genetic Diagnostics,Eurofins Clinical Diagnostics
criteria provided, single submitter

(EGL Classification Definitions)
Pathogenic
(Jul 5, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes27not providednot provided17not providedliterature only
not providedgermlineunknown2not providednot providednot providednot providedclinical testing
Mediterraneangermlineunknownnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

IVS-I-1 (G-->C) in combination with -42 (C-->G) in the promoter region of the beta-globin gene in patients from Tajikistan.

Fedorov AN, Nasyrova FYu, Smirnova EA, Bocharova TN, Limborska SA.

Hemoglobin. 1993 Jun;17(3):275-8. No abstract available.

PubMed [citation]
PMID:
8330981

The peculiar spectrum of beta-thalassemia genes in Tunisia.

Chibani J, Vidaud M, Duquesnoy P, Bergé-Lefranc JL, Pirastu M, Ellouze F, Rosa J, Goossens M.

Hum Genet. 1988 Feb;78(2):190-2.

PubMed [citation]
PMID:
3422218
See all PubMed Citations (26)

Details of each submission

From GeneReviews, SCV000040709.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Mediterraneannot providednot providednot providedliterature onlynot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory Corporation of America, SCV000052633.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided20not providednot providedcuration PubMed (25)
2not provided7not providednot providedcuration PubMed (25)
3not providednot providednot providednot providedclinical testing PubMed (25)

Description

"Common DV in Mediterranean populations; The variant is reported to have an allele frequency of 6.4% in Egypt; numbers are fabricated here to saturate the tbGP score since this is a common DV."
"Seven patients compound heterozygous for the variant and a BTHAL variant (DV) are clinically diagnosed with BTHAL; controls not tested."

Description

Converted during submission to Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes10not providednot provided20not providednot providednot provided
2germlineyes7not providednot provided7not providednot providednot provided
3germlineunknownnot providedBloodassert pathogenicitynot providednot providednot provided See 3

Co-occurrences

#ZygosityAllelesNumber of Observations
3SingleHeterozygoteHBB:c.9T>C, HBB:c.316-185C>T, HBB:c.315+16G>C, HBB:c.-31C>T1

From EGL Genetic Diagnostics,Eurofins Clinical Diagnostics, SCV000331532.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Dec 26, 2017